Intriguingly, we determined that NEDD9 inhibition results in the statistically significant elevation of ERCC4 expression levels in three human and two murine NSCLC cell lines (Figure 4A and Figure S4A). Here, NEDD9 is linked to non-small cell lung carcinoma.